Sign in to view content

First Time Results of VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy

Omer Trivizki, MD, MBA

Video
Published 2025

Related

Beyond Complement: A Novel FAS Inhibition Approach for Neuroprotection in GA
Vaidehi S. Dedania, MD
Updates from the Field
2024
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss
Jennifer K. Sun, MD
Updates from the Field
2019
Suprachoroidal Delivery of RGX-314 for Neovascular AMD: Initial Results From the Phase II AAVIATE Study
Mark R. Barakat, MD
Annual Meeting Talks
2021

Category: AMD-Non-Neovascular

See more